Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
Crossref DOI link: https://doi.org/10.1007/s40258-017-0352-8
Published Online: 2017-10-04
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schnippel, Kathryn http://orcid.org/0000-0003-0757-4325
Firnhaber, Cynthia
Conradie, Francesca
Ndjeka, Norbert
Sinanovic, Edina
License valid from 2017-10-04